Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring liver cancer biology through functional genetic screens
Cun Wang, Ying Cao, Chen Yang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 10, pp. 690-704
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Changyu Yao, Shilun Wu, Jian Kong, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 1, pp. 25-43
Open Access | Times Cited: 70
The advanced development of molecular targeted therapy for hepatocellular carcinoma
Tao Yan, Lingxiang Yu, Ning Zhang, et al.
Cancer Biology and Medicine (2022) Vol. 19, Iss. 6, pp. 1-16
Open Access | Times Cited: 37
Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis
Honglu Zhang, Jiyong Liu
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Lysyl hydroxylase LH1 promotes confined migration and metastasis of cancer cells by stabilizing Septin2 to enhance actin network
Zihan Yang, Li Zhou, Tongxu Si, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells
Yinda Qiu, Qi Yan, Yi Wang, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1276-1286
Closed Access | Times Cited: 5
CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer
Yanfeng Liu, Fan Wang, Guoquan Yan, et al.
Cancer Letters (2024) Vol. 595, pp. 217006-217006
Closed Access | Times Cited: 5
Unraveling the causal relationship and underlying mechanisms between cathepsins on liver cancer: findings from mendelian randomization and bioinformatics analysis
Xiaoxue Wang, Zexin Zhu
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Comprehensive review of the vascular niche in regulating liver regeneration, fibrosis, and hepatocellular carcinoma
Yutian Chen, Yangfan Zhou, Peipei Li, et al.
Deleted Journal (2025) Vol. 2, Iss. 2, pp. 100070-100070
Closed Access
Glutamine metabolic reprogramming in hepatocellular carcinoma
Yanyan Ye, Bodong Yu, Hua Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 12
SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells
Jianxu Chen, Zhijie Xu, Hongbin Huang, et al.
JCI Insight (2023) Vol. 8, Iss. 18
Open Access | Times Cited: 11
Fluorescence imaging sheds light on the immune evasion mechanisms of hepatic stellate cells mediated by superoxide anion
Yuantao Mao, Chuanchen Wu, Xin Wang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer
Yangyang Zhou, Siying Wang, Wei Wu, et al.
EBioMedicine (2022) Vol. 87, pp. 104397-104397
Open Access | Times Cited: 13
DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy
Liang Zhang, Jiawei Hong, Wei Chen, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3412-3427
Open Access | Times Cited: 7
Ropivacaine combined with sorafenib attenuates hepatocellular carcinoma cell proliferation and metastasis by inhibiting the miR‐224/HOXD10 axis
Wenting Wang, Tao Wang, Hongyun Lin, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 4, pp. 2429-2438
Closed Access | Times Cited: 2
Cost-effectiveness analysis of Tislelizumab vs Sorafenib as the first-line treatment of unresectable hepatocellular carcinoma
Qiuping Chen, Quan Sun, Jing Zhang, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0295090-e0295090
Open Access | Times Cited: 2
Therapeutic targeting of PLK1 in TERT promoter‐mutant hepatocellular carcinoma
Qin Tang, Guanghui Hu, Ye Sang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 2
Mapping the landscape of synthetic lethal interactions in liver cancer
Yang Chen, Yuchen Guo, Ruolan Qian, et al.
Theranostics (2021) Vol. 11, Iss. 18, pp. 9038-9053
Open Access | Times Cited: 17
Expression and functions of transient receptor potential channels in liver diseases
Wenhui Wang, Pengyu Liu, Yalin Zhang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 445-459
Open Access | Times Cited: 12
Dual role of ANGPTL8 in promoting tumor cell proliferation and immune escape during hepatocarcinogenesis
Yujiu Gao, Yue Yuan, Wen Shu, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Diallyl trisulfide induces pro-apoptotic autophagy via the AMPK/SIRT1 signalling pathway in human hepatocellular carcinoma HepG2 cell line
Shuoshuo Sun, Xiyu Liu, Xiao Wei, et al.
Food & Nutrition Research (2023) Vol. 66
Open Access | Times Cited: 6
Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line
Chaoji Shi, Ziyue Gu, Shengming Xu, et al.
Cancer Communications (2022) Vol. 42, Iss. 7, pp. 627-647
Open Access | Times Cited: 9
Role of ER Stress in Xenobiotic-Induced Liver Diseases and Hepatotoxicity
Yujing Zhang, Yuchen Qi, Shuai Huang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 9
Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling
Franco Cecchi, Karen Rex, Joanna Schmidt, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 460-460
Open Access | Times Cited: 5
Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically
Liuyun Gong, Yinliang Lu, Jing Wang, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 6, pp. 603-615
Open Access | Times Cited: 5
The combined characteristics of cholesterol metabolism and the immune microenvironment may serve as valuable biomarkers for both the prognosis and treatment of hepatocellular carcinoma
Weiyu Bai
Heliyon (2023) Vol. 9, Iss. 12, pp. e22885-e22885
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top